TG Biotech

TG Biotech is a South Korean biotechnology company founded in 2000, specializing in the research and development of health functional foods and natural pharmaceuticals derived from botanical resources. The company is best known for discovering the world's first obesity-related gene (IDPc) and developing Actiponin®, a patented natural AMPK activator clinically proven to support weight management and metabolic health. TG Biotech operates a research institute focused on identifying molecular targets and mechanisms of action for bioactive ingredients, with a pipeline extending into botanical drug development for metabolic disorders and neurodegenerative diseases. Headquartered in Daegu, the company maintains a strong global presence through partnerships with major health supplement brands and holds numerous patents in Korea, the U.S., Japan, and China.